Skip to main content

Commentary

Pharmacy Learning Network
Soumya Vishwanath, PharmD, University of Massachusetts Medical School, discusses digital therapeutics, which she says is the next wave of patient care, and highlights why it’s essential to assess how these products may play a role in clinical therapy and evaluate their impact on key stakeholders.
Pharmacy Learning Network
In this week’s issue of Talking Therapeutics, Dr Jennings explores a new drug approval and what it means for patients with chronic kidney disease.
Pharmacy Learning Network
“Goal-directed use of antihypertensives and statin drugs appear to be effective strategies to reduce atrial fibrillation incidence, morbidity, and mortality,” says Mark Munger, PharmD.
First Report Managed Care
Jenn Dellwo, Icario, introduces an innovative, closed-loop survey approach focused on capturing member experiences early to proactively impact satisfaction ahead of the CAHPS survey.
Annals of Long-Term Care
Michael Gordon, MD, MSc, FRCPC, discusses his early experiences with electroconvulsive therapy (ECT)—treatment often used for patients with severe depression—and highlights how the balance of antidepressant treatment and ECT has shifted over time to benefit severely depressed older patients.
Annals of Long-Term Care
Brittany H Cone, Esq, and Jordan S Johnson, Esq, attorneys at Hall Booth Smith, PC, talk through the Medicaid program, current practical issues that the long-term care industry is facing, and provide a few possible approaches and solutions to these issues.
Pharmacy Learning Network
In this week’s issue of Talking Therapeutics, Dr Jennings explores the science and promise of a recently approved novel medication for patients with HFrEF.
Veterans Health Today
Victor Murray, Air Force veteran and prostate cancer survivor, explains why he urges Congress to work more with the VA to expand access to high-intensity focused ultrasound and focused ultrasound therapy for America’s veterans.
Annals of Long-Term Care
“Rather than dismissing the fears and concerns of our staff, we need to find ways of addressing the staff where they are,” says Ilene Warner-Maron, PhD. “These concerns cannot be mandated away but must be addressed with empathy, education, and support.”
Pharmacy Learning Network
Dr Jennings reviews evidence supporting colchicine use to further reduce residual disease burden in coronary artery disease but highlights why pharmacists need to keep several things in mind when dispensing colchicine to ensure that patients are kept safe.
Back to Top